469 related articles for article (PubMed ID: 16907910)
1. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
Löfdahl JM; Wahlström J; Sköld CM
Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
[TBL] [Abstract][Full Text] [Related]
3. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
4. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage.
Stríz I; Wang YM; Svarcová I; Trnka L; Sorg C; Costabel U
Eur Respir J; 1993 Oct; 6(9):1287-94. PubMed ID: 7904572
[TBL] [Abstract][Full Text] [Related]
5. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.
Hodge S; Hodge G; Ahern J; Jersmann H; Holmes M; Reynolds PN
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):748-55. PubMed ID: 17630319
[TBL] [Abstract][Full Text] [Related]
6. Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages.
Sköld CM; Lundahl J; Halldén G; Hallgren M; Eklund A
Clin Exp Immunol; 1996 Oct; 106(1):108-13. PubMed ID: 8870707
[TBL] [Abstract][Full Text] [Related]
7. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease.
Pons AR; Sauleda J; Noguera A; Pons J; Barceló B; Fuster A; Agustí AG
Eur Respir J; 2005 Jul; 26(1):60-6. PubMed ID: 15994390
[TBL] [Abstract][Full Text] [Related]
8. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma.
Viksman MY; Liu MC; Bickel CA; Schleimer RP; Bochner BS
Am J Respir Crit Care Med; 1997 Mar; 155(3):858-63. PubMed ID: 9117017
[TBL] [Abstract][Full Text] [Related]
10. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
11. Increased intraepithelial T-cells in stable COPD.
Löfdahl MJ; Roos-Engstrand E; Pourazar J; Bucht A; Dahlen B; Elmberger G; Blomberg A; Sköld CM
Respir Med; 2008 Dec; 102(12):1812-8. PubMed ID: 18706796
[TBL] [Abstract][Full Text] [Related]
12. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
13. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
[TBL] [Abstract][Full Text] [Related]
14. [Alveolar macrophage and airway inflammation in patients with chronic obstructive pulmonary disease].
Chen P; Cai S; Zhu Y; Peng H; Luo H; Liu J
Zhonghua Nei Ke Za Zhi; 2001 Apr; 40(4):232-5. PubMed ID: 11798582
[TBL] [Abstract][Full Text] [Related]
15. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between subpopulations of regulatory T cells in COPD.
Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD.
Pons AR; Noguera A; Blanquer D; Sauleda J; Pons J; Agustí AG
Eur Respir J; 2005 Apr; 25(4):647-52. PubMed ID: 15802338
[TBL] [Abstract][Full Text] [Related]
18. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
19. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease.
Domagała-Kulawik J; Maskey-Warzechowska M; Hermanowicz-Salamon J; Chazan R
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():75-84. PubMed ID: 17072032
[TBL] [Abstract][Full Text] [Related]
20. [Airway inflammation and macrophage inflammatory protein-1alpha, gelatinase B level in patients with COPD].
Cai S; Chen P; Zhu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jul; 24(7):429-32. PubMed ID: 11803002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
